Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19)
-
Angiotensin-converting enzyme-2 (ACE2) receptor is the known receptor for SARS-CoV-2 as well as coronavirus NL63
-
ACE2 receptor is expressed on the surface of type 2 pneumocytes in the lungs
-
In samples taken from patients who smoke, an upregulation of ACE2 receptor could be seen in the airway epithelium
-
In particular, ACE2 receptor was expressed at a higher concentration in the pneumocytes, alveolar macrophages, and the apical end of the small airway epithelium in smoking patients compared to non-smoking patients
-
Previous observations show that SARS-COV-2 adhesion downmodulates ACE2 enzyme expression, increasing production and activation of other ACE enzymes leading to severe acute respiratory failure
-
Overall, it was observed that smoking upregulates ACE2 receptor and this could be true for electronic cigarette users as well
-
This upregulation is dangerous as SARS-CoV-2 utilizes this receptor to infect the airway epithelium, leading to severe acute respiratory failure
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
ACE2 Expression is Increased in the Small Airway Epithelium of Smokers vs. Nonsmokers
ACE2 Expression is Increased in the Small Airway Epithelium of Male Smokers vs. Female Smokers and Nonsmokers
Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19)